May 2024 European Commission grants PUMA
COMMISSION IMPLEMENTING DECISION of 27.5.2024 granting a paediatric use marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council and Regulation (EC) 1901/2006 of the European Parliament and of the Council for “Neoatricon – dopamine hydrochloride”